Citigroup’s Asensus Surgical, Inc. ASXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,047
| Closed | -$2K | – | 5777 |
|
|
2023
Q1 | $2K | Buy |
+3,047
| New | +$2.06K | ﹤0.01% | 5090 |
|
|
2022
Q3 | – | Sell |
-2,426
| Closed | -$1K | – | 6449 |
|
|
2022
Q2 | $1K | Sell |
2,426
-56,736
| -96% | -$25.3K | ﹤0.01% | 6126 |
|
|
2022
Q1 | $37K | Sell |
59,162
-124,621
| -68% | -$96K | ﹤0.01% | 4867 |
|
|
2021
Q4 | $204K | Buy |
183,783
+56,671
| +45% | +$87.6K | ﹤0.01% | 4349 |
|
|
2021
Q3 | $235K | Buy |
127,112
+22,066
| +21% | +$49.6K | ﹤0.01% | 4045 |
|
|
2021
Q2 | $333K | Buy |
105,046
+93,614
| +819% | +$234K | ﹤0.01% | 3952 |
|
|
2021
Q1 | $37K | Buy |
+11,432
| New | +$41.4K | ﹤0.01% | 4881 |
|
|
2020
Q4 | – | Sell |
-1
| Closed | – | – | 7679 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7638 |
|
|
2020
Q2 | $0 | Sell |
1
-4,868
| -100% | -$2.35K | ﹤0.01% | 7712 |
|
|
2020
Q1 | $2K | Buy |
4,869
+1,202
| +33% | +$1.25K | ﹤0.01% | 7453 |
|
|
2019
Q4 | $5K | Sell |
3,667
-965
| -21% | -$3.35K | ﹤0.01% | 7411 |
|
|
2019
Q3 | $37K | Sell |
4,632
-941
| -17% | -$12.8K | ﹤0.01% | 6326 |
|
|
2019
Q2 | $99K | Buy |
5,573
+2,832
| +103% | +$62K | ﹤0.01% | 5886 |
|
|
2019
Q1 | $85K | Sell |
2,741
-1,844
| -40% | -$61.8K | ﹤0.01% | 5906 |
|
|
2018
Q4 | $134K | Sell |
4,585
-2,353
| -34% | -$107K | ﹤0.01% | 5409 |
|
|
2018
Q3 | $523K | Buy |
6,938
+5,215
| +303% | +$353K | ﹤0.01% | 4224 |
|
|
2018
Q2 | $98K | Buy |
1,723
+1,085
| +170% | +$39.5K | ﹤0.01% | 5750 |
|
|
2018
Q1 | $14K | Sell |
638
-553
| -46% | -$12.7K | ﹤0.01% | 6925 |
|
|
2017
Q4 | $29K | Buy |
1,191
+834
| +234% | +$25.7K | ﹤0.01% | 6528 |
|
|
2017
Q3 | $7K | Buy |
357
+150
| +72% | +$1.75K | ﹤0.01% | 6785 |
|
|
2017
Q2 | $2K | Sell |
207
-158
| -43% | -$1.5K | ﹤0.01% | 7043 |
|
|
2017
Q1 | $6K | Sell |
365
-5,135
| -93% | -$89K | ﹤0.01% | 6750 |
|
|
2016
Q4 | $93K | Buy |
5,500
+4,430
| +414% | +$90.8K | ﹤0.01% | 5823 |
|
|
2016
Q3 | $23K | Buy |
1,070
+194
| +22% | +$3.55K | ﹤0.01% | 6137 |
|
|
2016
Q2 | $14K | Sell |
876
-2,383
| -73% | -$74.8K | ﹤0.01% | 6387 |
|
|
2016
Q1 | $180K | Buy |
3,259
+1,985
| +156% | +$85K | ﹤0.01% | 5188 |
|
|
2015
Q4 | $41K | Buy |
1,274
+1,020
| +402% | +$32.9K | ﹤0.01% | 6083 |
|
|
2015
Q3 | $8K | Sell |
254
-23
| -8% | -$853 | ﹤0.01% | 6564 |
|
|
2015
Q2 | $11K | Buy |
277
+90
| +48% | +$4.15K | ﹤0.01% | 6428 |
|
|
2015
Q1 | $7K | Sell |
187
-257
| -58% | -$9.7K | ﹤0.01% | 6617 |
|
|
2014
Q4 | $17K | Buy |
444
+226
| +104% | +$9.33K | ﹤0.01% | 6293 |
|
|
2014
Q3 | $12K | Buy |
218
+199
| +1,047% | +$10.7K | ﹤0.01% | 6184 |
|
|
2014
Q2 | $1K | Buy |
+19
| New | +$1.1K | ﹤0.01% | 6973 |
|
Other funds holding ASXC
MCM
GCP
AA
Citigroup's ASXC Position: Q2 2023 in Review
Citigroup sold out of Asensus Surgical, Inc. (ASXC) in Q2 2023, closing a stake of 3,047 shares — an estimated $2K sold.
Citigroup first reported a position in ASXC in Q2 2014 and held it in 33 quarters. The position peaked at $523K in Q3 2018. 80 funds tracked by Wall St. Rank hold ASXC as of Q2 2023.
- Citigroup reported no remaining Asensus Surgical, Inc. position as of Q2 2023 after selling out during the quarter.
- Citigroup sold 3,047 Asensus Surgical, Inc. shares in Q2 2023, an estimated $2K.
- Citigroup first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 33 quarters.
- Citigroup's Asensus Surgical, Inc. position peaked at $523K in Q3 2018.
- 80 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2023.
Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.